ADC Therapeutics raises $200 Million in private placing to fund registrational trials of its lead anti-cancer drugs. - ETCapital

Shanghai skyline at sunset featuring the Shanghai Tower, Shanghai World Financial Center, and Oriental Pearl Tower in Pudong, China.

1

October 2017

ADC Therapeutics raises $200 Million in private placing to fund registrational trials of its lead anti-cancer drugs.

Location: